Related Experiment Video

Updated: May 9, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Guidance for National Tuberculosis Programmes on the management of tuberculosis in children - an update

Steve M Graham1

  • 1Department of Paediatrics, College of Medicine, Blantyre

Malawi Medical Journal : the Journal of Medical Association of Malawi
|July 24, 2013
PubMed

Insights

Childhood tuberculosis (TB) requires tailored approaches. Guidelines emphasize early diagnosis, prompt treatment, and preventive isoniazid therapy for child contacts of infectious TB cases.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Childhood tuberculosis (TB) affects approximately one million children globally each year.
  • Childhood TB represents a significant portion (12%) of all TB cases in Malawi, highlighting regional disparities.
  • Key differences exist between childhood and adult TB, impacting prevention, diagnosis, and treatment strategies.

Purpose of the Study:

  • To summarize critical information and recommendations from the 2006 Stop TB Partnership Childhood TB Subgroup guidelines.
  • To address the need for improved diagnosis, management, and prevention of TB in children.
  • To ensure children are integrated into national TB control efforts and the Stop TB strategy.

Main Methods:

  • Review and summarization of the 2006 guidelines published by the Stop TB Partnership Childhood TB Subgroup.
  • Focus on recommendations for screening household contacts of smear-positive pulmonary TB cases.
  • Emphasis on identifying children with TB for prompt treatment and providing preventive therapy.

Main Results:

  • Household contact screening is crucial for identifying children with TB and initiating treatment.
  • Isoniazid preventive therapy is recommended for child contacts without active TB disease.
  • The guidelines aim to fill existing gaps in childhood TB management.

Conclusions:

  • Early identification and effective management of childhood TB are essential.
  • Implementing tailored strategies for children is vital for controlling the global TB burden.
  • Strengthened national TB programs are needed to address childhood TB comprehensively.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...